Table of Contents:
  • Contents: Liquid biopsy
  • Cell-free circulating tumor DNA (ctDNA)
  • Droplet digital PCR
  • Colorectal cancer
  • Anti-EGFR therapy
  • CHRONOS trial
  • Cetuximab
  • Entrectinib
  • Blood vs urine-based liquid biopsy
  • BEAMing technology
  • MAP2K1 p.K57 mutations
  • Minimal Residual Disease (MRD)